Catalyst Wire Dossier Catalyst Wire Dossier

rhuMAb Beta7

· Genentech, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for rhuMAb Beta7, covering 2016-08-12 to 2016-11-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis [Phase 1]

See pricing